logo
Select company
Select metric
$ -1.53EBITDA per Share
VS
Market
14
Sector
38
Industry
51
History
71
$ 3.7Close
$ 0.88 - $ 4.74 52-Week Range
Ticker Information

Ticker

PYXS

Company Name

PYXIS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PYXIS ONCOLOGY INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PYXS - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -95.04M$ -1.53161.92M
3/31/2025$ -94.25M$ -1.54161.05M
12/31/2024$ -75.81M$ -1.3158.45M
9/30/2024$ -53.53M$ -0.88160.72M
6/30/2024$ -55.61M$ -0.92160.5M
3/31/2024$ -54.27M$ -1.06151.29M
12/31/2023$ -71.2M$ -1.78139.9M
9/30/2023$ -92.12M$ -2.23141.33M
6/30/2023$ -96.92M$ -2.52138.39M
3/31/2023$ -106.8M$ -3.02135.35M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PYXIS ONCOLOGY INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.89.
  • Over the past 5 years, PYXIS ONCOLOGY INC's average EBITDAPS has been $ -2.45.
  • The median EBITDAPS for PYXIS ONCOLOGY INC during this period was $ -1.89
  • PYXIS ONCOLOGY INC reached its highest EBITDAPS over the past 5 years at $ -0.88.
  • The lowest EBITDAPS recorded by PYXIS ONCOLOGY INC in the same timeframe $ -8.8

PYXIS ONCOLOGY INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
NTRB : NUTRIBAND INC $ -0.89ALGS : ALIGOS THERAPEUTICS INC $ -5.68STTK : SHATTUCK LABS INC $ -1.12ORMP : ORAMED PHARMACEUTICALS INC $ -0.84CAMP : CAMP4 THERAPEUTICS CORP $ -2.39ARMP : ARMATA PHARMACEUTICALS INC $ -0.29DTIL : PRECISION BIOSCIENCES INC $ -6.67NRXS : NEURAXIS INC $ -0.82CBUS : CIBUS INC $ -5.64ABVC : ABVC BIOPHARMA INC $ -0.14

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for PYXIS ONCOLOGY INC is calculated as follows: EBITDA [ $ -12.41M ] / (Shares WA [ 6.55M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.89 ]

PYXS - EBITDA per Share, Last 5 years

$ -8.8

Minimum

Dec 31, 2021

$ -0.88

Maximum

Sep 30, 2024

$ -2.45

Average

$ -1.89

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28